Showing results (161-170 of 267) with videos related to

Sort By:
Pageof 27
Reviews of Infectious Diseases|July 1, 1983
Clinical study of combination therapy with oxacillin and rifampin for staphylococcal infectionsP Van der Auwera, F Meunier-Carpentier, J Klastersky
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1994
Salmonella infections in a cancer centerL M Noriega, P Van der Auwera, D Daneau, et al.
International Journal of Antimicrobial Agents|January 23, 1999
Imipenem versus targeted therapy in cancer patientsM Aoun, F Crokaert, M Paesmans, et al.
The Journal of Infectious Diseases|September 1, 1976
Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serumJ Klastersky, F Meunier-Carpentier, J M Prevost, et al.
Archives Internationales De Physiologie Et De Biochimie|December 1, 1986
Influence of various antibiotics on superoxide generation by normal human neutrophilsP Van der Auwera, G Petrikkos, M Husson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2003
Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 casesP Fanourgiakis, M Vekemans, A Georgala, et al.
Presse Medicale (Paris, France : 1983)|January 7, 1989
[Prevention using pefloxacin of infections in cancer patients with granulocytopenia]A Leleux, R Snoeck, J Gerain, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1980
Carbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind studyJ Klastersky, L Coppens, F Meunier-Carpentier, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 8, 2017
Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studiesF Lebrun, J Klastersky, D Levacq, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1986
Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosaP Van der Auwera, J Klastersky, H Lagast, et al.
Pageof 27